GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » ROIC %

Curatis Holding AG (CHIX:CURNZ) ROIC % : -48.79% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Curatis Holding AG's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was -48.79%.

As of today (2024-06-21), Curatis Holding AG's WACC % is 27.19%. Curatis Holding AG's ROIC % is -38.56% (calculated using TTM income statement data). Curatis Holding AG earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Curatis Holding AG ROIC % Historical Data

The historical data trend for Curatis Holding AG's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG ROIC % Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
ROIC %
-1,952.38 -22.75 -48.01

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROIC % Get a 7-Day Free Trial -1,590.48 -7.01 -4.42 -28.78 -48.79

Competitive Comparison of Curatis Holding AG's ROIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG's ROIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's ROIC % distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's ROIC % falls into.



Curatis Holding AG ROIC % Calculation

Curatis Holding AG's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-3.535 * ( 1 - 2.72% )/( (14.068 + 0.258)/ 2 )
=-3.438848/7.163
=-48.01 %

where

Curatis Holding AG's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-3.182 * ( 1 - 2.76% )/( (12.425 + 0.258)/ 2 )
=-3.0941768/6.3415
=-48.79 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curatis Holding AG  (CHIX:CURNz) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Curatis Holding AG's WACC % is 27.19%. Curatis Holding AG's ROIC % is -38.56% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Curatis Holding AG ROIC % Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG (CHIX:CURNZ) Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057
Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG (CHIX:CURNZ) Headlines

No Headlines